HIMS
Hims & Hers Health, Inc. (HIMS)
Last Price$40.7(9.8%)
Market Cap$9,261.6M
$1,476.5M
+69.3% YoY
$126.0M
N/A
($288.9M)
Net Debt to FCF - (1.5x)
$198.3M
13.4% margin

HIMS Income Statement

HIMS Income Statement Overview

Annual
Quarterly
LTM
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
$872.0M 65.5% YoY
$714.9M 74.9% YoY
82.0% margin
Cost of revenue
$157.1M 32.9% YoY
Operating expenses
$744.4M 55.9% YoY
Net income
$23.5M (64.1%) YoY
(2.7%) margin
Other: $20.1M
R&D
$48.2M 65.0% YoY
5.5% of revenue
SG&A
$692.7M 86.8% YoY
79.4% of revenue

HIMS Income statement key metrics

Annual
Quarterly
LTM

Revenue

$872.0M +65.5% YoY

Operating Income

($29.5M) -57.1% YoY

Net Income

($23.5M) -64.1% YoY

HIMS Balance Sheet

HIMS Balance Sheet Overview

Annual
Quarterly
LTM
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$441.2M
Current assets ($265.1M, 60.1% of total)
$221.0M (50.1%)
$5,705.0K (1.3%)
Other current assets
$38.4M (8.7%)
Non-current assets ($176.1M, 39.9% of total)
$18.6M (4.2%)
Other non-current assets
$111.8M (25.3%)
Financial position
($209.8M)
$221.0M$11.2M
Cash & Short-term Investments
Total Debt

HIMS Balance Sheet Metrics

Annual
Quarterly
LTM

Assets

$441.2M +20.4% YoY

Liabilities

$97.2M +77.9% YoY

Shareholder's Equity

$344.0M +10.4% YoY

HIMS Cash Flow Statement

HIMS Cash Flow Statement Overview

Annual
Quarterly
LTM
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Cash Beginning of PeriodOperating Cash FlowInvesting Cash FlowFinancing Cash FlowForex Changes on CashCash End of Period$47.6M$73.5M($12.1M)($11.5M)($11.0K)$97.5M

HIMS Cash Flow Statement key metrics

Annual
Quarterly
LTM

Capital Expenditure (CAPEX)

($26.5M) +265.6% YoY

Free Cash Flow (FCF)

$47.0M N/A YoY

HIMS Financials

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
% growth
26.7
0.0%
82.6
209.4%
148.8
80.2%
271.9
82.8%
526.9
93.8%
872.0
65.5%
Cost of Goods Sold (COGS)18.938.039.367.4118.2157.1
% margin
7.8
29.2%
44.6
54.0%
109.5
73.6%
204.5
75.2%
408.7
77.6%
714.9
82.0%
Operating Expenses83.6119.0124.6319.5477.4744.4
Research & Development Expenses (R&D)0.00.011.222.429.248.2
Selling, General & Administrative Expenses (SG&A)83.6119.0124.6319.5370.8692.7
(75.8)
(284.0%)
(74.4)
(90.1%)
(15.1)
(10.2%)
(115.0)
(42.3%)
(68.7)
(13.0%)
(29.5)
(3.4%)
Interest Income0.61.90.40.42.60.0
Interest Expense0.00.40.00.00.00.0
Pre-tax Income(75.2)(72.0)(18.0)(110.8)(65.7)(21.6)
% effective tax rate
0.0
(0.0%)
0.1
(0.1%)
0.1
(0.7%)
(3.1)
2.8%
(0.0)
0.0%
2.0
(9.2%)
% margin
(75.2)
(282.0%)
(72.1)
(87.3%)
(18.1)
(12.2%)
(107.7)
(39.6%)
(65.7)
(12.5%)
(23.5)
(2.7%)
EPS(1.12)(2.86)(0.51)(0.58)(0.32)(0.11)
Diluted EPS(1.12)(2.86)(0.51)(0.58)(0.32)(0.11)
% margin
0.0
0.0%
(74.2)
(89.8%)
(14.1)
(9.5%)
(111.0)
(40.8%)
(61.2)
(11.6%)
(19.9)
(2.3%)